{"id":"https://openalex.org/W2809928675","doi":"https://doi.org/10.1007/s11095-018-2448-8","title":"First Infusion Reactions are Mediated by Fc\u03b3RIIIb and Neutrophils","display_name":"First Infusion Reactions are Mediated by Fc\u03b3RIIIb and Neutrophils","publication_year":2018,"publication_date":"2018-06-27","ids":{"openalex":"https://openalex.org/W2809928675","doi":"https://doi.org/10.1007/s11095-018-2448-8","mag":"2809928675","pmid":"https://pubmed.ncbi.nlm.nih.gov/29951887","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6021477"},"language":"en","primary_location":{"id":"doi:10.1007/s11095-018-2448-8","doi":"https://doi.org/10.1007/s11095-018-2448-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11095-018-2448-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11095-018-2448-8.pdf","source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s11095-018-2448-8.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076327726","display_name":"Felix C. Weber","orcid":"https://orcid.org/0000-0003-3367-5795","observed_orcids":["https://orcid.org/0000-0003-3367-5795"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Felix Weber","raw_affiliation_strings":["Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Bldg 93 Room 5.10, Grenzacherstrasse 124, 4070, Basel, CH, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Bldg 93 Room 5.10, Grenzacherstrasse 124, 4070, Basel, CH, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081666382","display_name":"Daniel Breustedt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Daniel Breustedt","raw_affiliation_strings":["Novartis Pharma AG, Novartis Institutes for Biomedical Research, Basel, Switzerland","Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Bldg 93 Room 5.10, Grenzacherstrasse 124, 4070, Basel, CH, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Novartis Institutes for Biomedical Research, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]},{"raw_affiliation_string":"Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Bldg 93 Room 5.10, Grenzacherstrasse 124, 4070, Basel, CH, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090540869","display_name":"Sonja Schlicht","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Sonja Schlicht","raw_affiliation_strings":["Small Molecule Research, Therapeutic Modalities, Roche Innovation Center Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Small Molecule Research, Therapeutic Modalities, Roche Innovation Center Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052159353","display_name":"Claas Aiko Meyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Claas A. Meyer","raw_affiliation_strings":["Small Molecule Research, Therapeutic Modalities, Roche Innovation Center Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Small Molecule Research, Therapeutic Modalities, Roche Innovation Center Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055050909","display_name":"Jens Niewoehner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jens Niewoehner","raw_affiliation_strings":["Large Molecule Research, Therapeutic Modalities, Roche Innovation Center Munich, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Large Molecule Research, Therapeutic Modalities, Roche Innovation Center Munich, Munich, Germany","institution_ids":["https://openalex.org/I4210094361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081844996","display_name":"Martin Ebeling","orcid":"https://orcid.org/0000-0002-0361-4636","observed_orcids":["https://orcid.org/0000-0002-0361-4636"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Martin Ebeling","raw_affiliation_strings":["Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Bldg 93 Room 5.10, Grenzacherstrasse 124, 4070, Basel, CH, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Bldg 93 Room 5.10, Grenzacherstrasse 124, 4070, Basel, CH, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109083013","display_name":"Per\u2010Ola Freskg\u00e5rd","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Per-Ola Freskgard","raw_affiliation_strings":["Neuroscience, Ophthalmology and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience, Ophthalmology and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080071412","display_name":"Peter Br\u00fcnker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Peter Bruenker","raw_affiliation_strings":["Large Molecule Research, Roche Innovation Center Zurich, Schlieren, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Large Molecule Research, Roche Innovation Center Zurich, Schlieren, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Thomas Singer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Thomas Singer","raw_affiliation_strings":["Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Bldg 93 Room 5.10, Grenzacherstrasse 124, 4070, Basel, CH, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Bldg 93 Room 5.10, Grenzacherstrasse 124, 4070, Basel, CH, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013470603","display_name":"Michael G. Reth","orcid":"https://orcid.org/0000-0002-1025-7198","observed_orcids":["https://orcid.org/0000-0002-1025-7198"]},"institutions":[{"id":"https://openalex.org/I161046081","display_name":"University of Freiburg","ror":"https://ror.org/0245cg223","country_code":"DE","type":"education","lineage":["https://openalex.org/I161046081"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael Reth","raw_affiliation_strings":["Institute of Biology III (Molecular Immunology), University of Freiburg, Freiburg im Breisgau, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Biology III (Molecular Immunology), University of Freiburg, Freiburg im Breisgau, Germany","institution_ids":["https://openalex.org/I161046081"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037588511","display_name":"Antonio H. Iglesias","orcid":"https://orcid.org/0000-0002-9528-5883","observed_orcids":["https://orcid.org/0000-0002-9528-5883"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Antonio Iglesias","raw_affiliation_strings":["Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Bldg 93 Room 5.10, Grenzacherstrasse 124, 4070, Basel, CH, Switzerland. antonio.iglesias@roche.com","Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Bldg 93 Room 5.10, Grenzacherstrasse 124, 4070, Basel, CH, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Bldg 93 Room 5.10, Grenzacherstrasse 124, 4070, Basel, CH, Switzerland. antonio.iglesias@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Bldg 93 Room 5.10, Grenzacherstrasse 124, 4070, Basel, CH, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5037588511"],"corresponding_institution_ids":["https://openalex.org/I118019719"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":{"value":4690,"currency":"USD","value_usd":4690},"fwci":1.5192,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.814058,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"35","issue":"9","first_page":"169","last_page":"169"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fcgammariiib","display_name":"FCGR3B","score":0.9359999895095825},{"id":"https://openalex.org/keywords/neutrophils","display_name":"neutrophils","score":0.9760000109672546},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8450000286102295},{"id":"https://openalex.org/keywords/fc-gamma-receptor","display_name":"Fc gamma receptor","score":0.8970000147819519},{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.7039999961853027},{"id":"https://openalex.org/keywords/transferrin-receptor","display_name":"transferrin receptor","score":0.8840000033378601},{"id":"https://openalex.org/keywords/hypothermia","display_name":"hypothermia","score":0.9079999923706055},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.8069999814033508},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.9829999804496765},{"id":"https://openalex.org/keywords/cd11b","display_name":"CD11b","score":0.8159999847412109},{"id":"https://openalex.org/keywords/fc-effector-functions","display_name":"Fc effector functions","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7206960916519165},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5201987624168396},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.48963338136672974},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.43698617815971375},{"id":"https://openalex.org/C25938499","wikidata":"https://www.wikidata.org/wiki/Q7663812","display_name":"Systemic administration","level":3,"score":0.4253327250480652},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.41896551847457886},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3945804536342621},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3636731505393982},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.16715160012245178},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07405903935432434},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007035","descriptor_name":"Hypothermia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D007035","descriptor_name":"Hypothermia","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D011990","descriptor_name":"Receptors, Transferrin","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D017452","descriptor_name":"Receptors, IgG","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D017452","descriptor_name":"Receptors, IgG","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058851","descriptor_name":"GPI-Linked Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D058851","descriptor_name":"GPI-Linked Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1007/s11095-018-2448-8","doi":"https://doi.org/10.1007/s11095-018-2448-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11095-018-2448-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11095-018-2448-8.pdf","source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4985805","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6021477","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6021477","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6021477","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharm Res","raw_type":"Text"},{"id":"pmid:29951887","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29951887","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical research","raw_type":"Journal Article"},{"id":"pmh:oai:freidok.uni-freiburg.de:270405","doi":null,"is_oa":false,"landing_page_url":"https://freidok.uni-freiburg.de/data/270405","pdf_url":null,"source":{"id":"https://openalex.org/S4306401057","display_name":"FreiDok plus (Universit\u00e4tsbibliothek Freiburg)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I161046081","host_organization_name":"University of Freiburg","host_organization_lineage":["https://openalex.org/I161046081"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutical Research. - 35, 9 (2018) , ISSN: 1573-904X","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s11095-018-2448-8","doi":"https://doi.org/10.1007/s11095-018-2448-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11095-018-2448-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11095-018-2448-8.pdf","source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309432","display_name":"F. Hoffmann-La Roche","ror":"https://ror.org/00by1q217"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2809928675.pdf","grobid_xml":"https://content.openalex.org/works/W2809928675.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W1503491996","https://openalex.org/W1528682116","https://openalex.org/W1532909735","https://openalex.org/W1557552070","https://openalex.org/W1572554526","https://openalex.org/W1608391010","https://openalex.org/W1862569453","https://openalex.org/W1881900824","https://openalex.org/W1936763432","https://openalex.org/W1970942128","https://openalex.org/W1988297612","https://openalex.org/W1998915656","https://openalex.org/W2016708646","https://openalex.org/W2029631026","https://openalex.org/W2041806010","https://openalex.org/W2057745345","https://openalex.org/W2058071683","https://openalex.org/W2063118071","https://openalex.org/W2084141237","https://openalex.org/W2088629488","https://openalex.org/W2089782191","https://openalex.org/W2097020324","https://openalex.org/W2100612316","https://openalex.org/W2112802871","https://openalex.org/W2159586298","https://openalex.org/W2168851595","https://openalex.org/W2181796219","https://openalex.org/W2317196925","https://openalex.org/W2330872912","https://openalex.org/W2343946691","https://openalex.org/W2515423876"],"related_works":["https://openalex.org/W3095030408","https://openalex.org/W2081324045","https://openalex.org/W2024737355","https://openalex.org/W3171783713","https://openalex.org/W3175418598","https://openalex.org/W2394947245","https://openalex.org/W7095563843","https://openalex.org/W7096587560","https://openalex.org/W1538460158","https://openalex.org/W2909328135"],"abstract_inverted_index":{"PURPOSE:":[0],"Administration":[1],"of":[2,80,191],"therapeutic":[3],"monoclonal":[4],"antibodies":[5],"(mAbs)":[6],"is":[7,20],"frequently":[8],"accompanied":[9,96],"by":[10,58,97,119,154],"severe":[11],"first":[12],"infusion":[13],"reactions":[14],"(FIR).":[15],"The":[16],"mechanism":[17],"driving":[18],"FIR":[19,34,44,75,108,125,151,178],"still":[21],"unclear.":[22],"This":[23],"study":[24],"aimed":[25],"to":[26,73,76,147,176],"investigate":[27],"the":[28],"cellular":[29],"and":[30,39,66,104,106,114,145,166,186],"molecular":[31],"mechanisms":[32],"causing":[33],"in":[35,46,100,126,179],"humanized":[36,50],"mouse":[37,85],"models":[38],"their":[40],"potential":[41],"for":[42,51,84,171],"evaluating":[43],"risk":[45],"patients.":[47],"METHODS:":[48],"Mice":[49],"Fc":[52],"gamma":[53],"receptors":[54],"(Fc\u03b3Rs)":[55],"were":[56,71,109],"generated":[57],"recombination-mediated":[59],"genomic":[60],"replacement.":[61],"Body":[62],"temperature,":[63],"cytokine":[64],"release":[65],"reactive":[67],"oxygen":[68],"species":[69],"(ROS)":[70],"measured":[72],"assess":[74],"mAbs.":[77,198],"RESULTS:":[78],"Infusion":[79],"human":[81,138],"mAb":[82],"specific":[83,197],"transferrin":[86],"receptor":[87],"(HamTfR)":[88],"into":[89],"Fc\u03b3R-humanized":[90],"mice,":[91],"produced":[92],"marked":[93],"transient":[94,189],"hypothermia":[95],"an":[98],"increase":[99],"inflammatory":[101],"cytokines":[102],"KC":[103],"MIP-2,":[105],"ROS.":[107],"dependent":[110],"on":[111,140,183],"administration":[112],"route":[113],"Fc-triggered":[115],"effector":[116],"functions":[117],"mediated":[118],"neutrophils.":[120],"Human":[121,164],"neutrophils":[122,141,156,167,192],"also":[123],"induced":[124],"wild":[127],"type":[128],"mice":[129,135],"infused":[130],"with":[131,160,196],"HamTfR.":[132],"Specific":[133],"knock-in":[134],"demonstrated":[136],"that":[137],"Fc\u03b3RIIIb":[139,159,165,195],"was":[142,152],"both":[143],"necessary":[144],"sufficient":[146],"cause":[148],"FIR.":[149,173],"Fc\u03b3RIIIb-mediated":[150],"abolished":[153],"depleting":[155],"or":[157,193],"blocking":[158,194],"CD11b":[161],"antibodies.":[162],"CONCLUSIONS:":[163],"are":[168],"primarily":[169],"responsible":[170],"triggering":[172],"Clinical":[174],"strategies":[175],"prevent":[177],"patients":[180],"should":[181],"focus":[182],"this":[184],"pathway":[185],"may":[187],"include":[188],"depletion":[190]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-07-10T00:00:00"}